Study Stopped
No Enrollments after COVID
Study of the Loss of AV Synchrony at Maximum Exercise
SLAVSME
SLAVSME - Study of the Loss of AV Synchrony at Maximum Exercise
1 other identifier
observational
9
1 country
1
Brief Summary
Investigators will identify a group of patients with complete heart block and a dual chamber pacemaker who will be expected to be able to exercise on a treadmill. Investigators will utilize symptom logs, cuff and continuous blood pressure monitoring. It is planned to study the symptomatic impact of loss of AV synchrony at significant levels of exercise.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Sep 2019
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 27, 2019
CompletedFirst Posted
Study publicly available on registry
March 1, 2019
CompletedStudy Start
First participant enrolled
September 10, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 10, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
April 10, 2023
CompletedApril 14, 2023
April 1, 2023
3.6 years
February 27, 2019
April 11, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
The number of participants with Loss of AV synchrony at maximum exercise
Baseline to end of stress test approximately 60 minutes.
Study Arms (1)
Participants with AV block with pacemaker
Participants will have a stress test, and results will be collected and recorded.
Interventions
Participants will reach maximum exercise on a treadmill and results will be collected and recorded.
Eligibility Criteria
patients from cardiology clinic
You may qualify if:
- Complete AV Block
- Age less than 60
- Easily programmable dual chamber pacemaker
You may not qualify if:
- Age \> 60
- Significant Heart Failure
- Significant angina
- History of claudication
- Significant orthopedic issues
- Evidence of sinus node dysfunction
- Taking beta blockers or non-dihydropyridine calcium channel blockers
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Vanderbilt University Medical Centerlead
- Medtroniccollaborator
Study Sites (1)
Vanderbilt University Medical Center
Nashville, Tennessee, 37232, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jay A. Montgomery, MD
Vanderbilt University Medical Center
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
February 27, 2019
First Posted
March 1, 2019
Study Start
September 10, 2019
Primary Completion
April 10, 2023
Study Completion
April 10, 2023
Last Updated
April 14, 2023
Record last verified: 2023-04